Protagonist Therapeutics Inc
PTGX
Company Profile
Business description
Protagonist Therapeutics Inc is a clinical-stage biopharmaceutical company having a proprietary technology platform that enables the discovery and development of novel constrained peptide-based drug candidates to address medical needs. Its pipeline products include Rusfertide (PTG-300) and JNJ-2113.
Contact
7707 Gateway Boulevard
Suite 140
NewarkCA94560
USAT: +1 510 474-0170
Sector
Healthcare
Stock type
Defensive
Industry
Biotechnology
Fiscal Year End
31 December 2025
Employees
124
Stocks News & Analysis
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 8,839.30 | 5.70 | 0.06% |
| CAC 40 | 7,754.55 | 16.13 | 0.21% |
| DAX 40 | 23,934.13 | 144.02 | 0.61% |
| Dow JONES (US) | 44,828.53 | 344.11 | 0.77% |
| FTSE 100 | 8,823.20 | 48.51 | 0.55% |
| HKSE | 23,921.81 | 148.13 | -0.62% |
| NASDAQ | 20,601.10 | 207.97 | 1.02% |
| Nikkei 225 | 39,730.16 | 55.74 | -0.14% |
| NZX 50 Index | 12,753.40 | 48.92 | 0.39% |
| S&P 500 | 6,279.35 | 51.93 | 0.83% |
| S&P/ASX 200 | 8,598.40 | 2.60 | 0.03% |
| SSE Composite Index | 3,475.24 | 14.09 | 0.41% |